Basic / Translational Research
Cancer Molecular Genetics/Early Detection Program
Program goal and objectives
This program aims to understand the basic molecular mechanism of tumorigenesis, identify biomarkers for early detection and targets for therapeutic intervention.
Members
- Kounosuke Watabe, Ph.D. (tumor biology, metatases)
- Yin-Yuan Mo, Ph.D. (tumor cell biology, drug resistance)
- Jodi Huggenvik, Ph.D. (tumor biology, tumor suppressors)
- Mike Collard, Ph.D. (tumor biology, tumor suppressors)
- Blaine Bartholomew, Ph.D. (cell biology, chromatin structure)
- Rita Trammell, Ph.D (tumor immunology, sarcoma)
- Lydia A. Arbogast, Ph.D. (hormone and cancer)
- Jena Steinle, Ph.D. (tumor angiogenesis)
- Sukesh R. Bhaumik, Ph.D. (Gene expression, DNA repair and cancer)
- Subhas Chakrabarty, Ph.D. (epigenomic remodeling and differentiation control)
- Randolph Elble, Ph.D. (cancer biology, tumor suppressors, CLCA protein)
- Deliang Cao, Ph.D. (metabolic pathways, antitumor activity & tumor selectivity)
- Daotai Nie, Ph.D. (molecular ordering in tumor progression)
- Dale Hales, Ph.D. (ovarian cancer prevention)
Experimental Therapeutics/Prevention Program
Program goal and objectivesThis program focuses on the development of new methodologies for cancer therapy and prevention.
Members
- Sophia Ran, Ph.D. (tumor biology, angiogenesis)
- Krishna Rao, M.D. (tumor genetics, breast cancer)
- Amy Arai, Ph.D. (neuroblastoma)
- Vickram Ramkumar, Ph.D. (signal transduction, chemotherapy)
- Leonard Rybak, M.D. (chemotherapy, drug sensitivity)
- Mary McAsey, Ph.D. (gynecologic cancer, chemoprevention)
- Kathy Campbell, Ph.D. (chemotherapy, anti-cancer drug)
- Gregory Brewer, Ph.D. (brain cancer)
- Laura Murphy, Ph.D. (breast cancer, chemoprevention)
- Yuqing Hou, Ph.D. (chemoprevention)
- Laura Rogers, M.D. (exercise and cancer)
- Subhas Chakrabarty, Ph.D. (chemoprevention of colon cancer)